Header cover image
  • Investing Ideas
  • Brazilian Pharmaceuticals & Biotech Undervalued based on future growth

Brazilian Pharmaceuticals & Biotech Undervalued based on future growth

Results

2

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Hypera

Market Cap: R$14.2b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$20.22

7D

-5.9%

1Y

-26.4%

Blau Farmacêutica

Market Cap: R$2.3b

A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

BLAU3

R$9.77

7D

-1.5%

1Y

-7.1%